Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Clinical Study of DD-687 in Healthy Japanese Infants
jRCT2080220899Phase 2
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of diphtheria toxoid + pertussis vaccine + tetanus toxoid + inactivated poliovirus vaccine in pertussis, diphtheria, Tetanus and 1 more, sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
diphtheria toxoid + pertussis vaccine + tetanus toxoid + inactivated poliovirus vaccine
03
Conditions
pertussisdiphtheriaTetanuspoliomyelitis
Beyond the preview
Go deeper on jRCT2080220899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220899.